The opioid drug that addicts don't like could be approved next spring

In studies, Nektar found opioid abusers rated its experimental, pain-killing opioid, which takes longer to reach the brain, as less likable than oxycodone.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.